Epitomee Medical Ltd
EPTMF
$0.9892
-$0.0327-3.20%
OTC PK
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.30M | -2.68M | -2.68M | -2.68M | 1.83M |
| Total Depreciation and Amortization | -317.00K | 99.00K | 99.00K | 99.00K | -487.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 414.00K | 454.50K | 454.50K | 454.50K | -3.31M |
| Change in Net Operating Assets | 227.00K | -40.50K | -40.50K | -40.50K | 758.00K |
| Cash from Operations | -1.97M | -2.17M | -2.17M | -2.17M | -1.21M |
| Capital Expenditure | -914.00K | -377.50K | -377.50K | -377.50K | -756.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.88M | 1.31M | 1.31M | 1.31M | 2.84M |
| Cash from Investing | 5.96M | 931.00K | 931.00K | 931.00K | 2.09M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -148.00K | -116.50K | -116.50K | -116.50K | -111.00K |
| Issuance of Common Stock | 1.00K | -- | -- | -- | 11.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -147.00K | -116.50K | -116.50K | -116.50K | -100.00K |
| Foreign Exchange rate Adjustments | -400.00K | -207.50K | -207.50K | -207.50K | 281.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.45M | -1.56M | -1.56M | -1.56M | 1.06M |